43
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Fragile X syndrome screening in Chinese children with unknown intellectual developmental disorder

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Fragile X syndrome is the most common genetic disorder of intellectual developmental disorder/mental retardation (IDD/MR). The prevalence of FXS in a Chinese IDD children seeking diagnosis/treatment in mainland China is unknown.

          Methods

          Patients with unknown moderate to severe IDD were recruited from two children’s hospitals. Informed consent was obtained from the children's parents. The size of the CGG repeat was identified using a commercial TP-PCR assay. The influence of AGG interruptions on the CGG expansion during maternal transmission was analyzed in 24 mother-son pairs (10 pairs with 1 AGG and 14 pairs with 2 AGGs).

          Results

          553 unrelated patients between six months and eighteen years of age were recruited. Specimens from 540 patients (male:female = 5.2:1) produced high-quality TP-PCR data, resulting in the determination of the FMR1 CGG repeat number for each. The most common repeat numbers were 29 and 30, and the most frequent interruption pattern was 2 or 3 AGGs. Five full mutations were identified (1 familial and 4 sporadic IDD patients), and size mosaicism was apparent in 4 of these FXS patients (4/5 = 80 %). The overall yield of FXS in the IDD cohort was 0.93 % (5/540). Neither the mean size of CGG expansion (0.20 vs. 0.79, p > 0.05) nor the frequency of CGG expansion (2/10 vs. 9/14, p > 0.05) was significantly different between the 1 and 2 AGG groups following maternal transmission.

          Conclusions

          The FMR1 TP-PCR assay generates reliable and sensitive results across a large number of patient specimens, and is suitable for clinical genetic diagnosis. Using this assay, the prevalence of FXS was 0.93 % in Chinese children with unknown IDD.

          Electronic supplementary material

          The online version of this article (doi:10.1186/s12887-015-0394-8) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references47

          • Record: found
          • Abstract: found
          • Article: not found

          De novo mutations in human genetic disease.

          New mutations have long been known to cause genetic disease, but their true contribution to the disease burden can only now be determined using family-based whole-genome or whole-exome sequencing approaches. In this Review we discuss recent findings suggesting that de novo mutations play a prominent part in rare and common forms of neurodevelopmental diseases, including intellectual disability, autism and schizophrenia. De novo mutations provide a mechanism by which early-onset reproductively lethal diseases remain frequent in the population. These mutations, although individually rare, may capture a significant part of the heritability for complex genetic diseases that is not detectable by genome-wide association studies.
            Bookmark
            • Record: found
            • Abstract: not found
            • Book: not found

            Diagnostic and statistical manual for mental disorders

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A point mutation in the FMR-1 gene associated with fragile X mental retardation.

              The vast majority of patients with fragile X syndrome show a folate-sensitive fragile site at Xq27.3 (FRAXA) at the cytogenetic level, and both amplification of the (CGG)n repeat and hypermethylation of the CpG island in the 5' fragile X gene (FMR-1) at the molecular level. We have studied the FMR-1 gene of a patient with the fragile X phenotype but without cytogenetic expression of FRAXA, a (CGG)n repeat of normal length and an unmethylated CpG island. We find a single point mutation in FMR-1 resulting in an lle367Asn substitution. This de novo mutation is absent in the patient's family and in 130 control X chromosomes, suggesting that the mutation causes the clinical abnormalities. Our results suggest that mutations in FMR-1 are directly responsible for fragile X syndrome, irrespective of possible secondary effects caused by FRAXA.
                Bookmark

                Author and article information

                Contributors
                cxlwx@sina.com
                wang66jm@163.com
                xiehua_2005@126.com
                hopewillcome@126.com
                dryewu@263.net
                colalawang@sina.cn
                mr_qinjian@126.com
                guoguo0520@sina.com
                gu325q@sina.com
                shellychenchina@sina.cn
                jitaoyun@163.com
                zangyu0612@sohu.com
                zhiminxiong@foxmail.com
                wangliwen2@vip.sina.com
                wxrwwn@gmail.com
                glatham@asuragen.com
                jiangyw@263.net
                Journal
                BMC Pediatr
                BMC Pediatr
                BMC Pediatrics
                BioMed Central (London )
                1471-2431
                15 July 2015
                15 July 2015
                2015
                : 15
                : 77
                Affiliations
                [ ]Municipal Key Laboratory of Child Development and Nutriomics, Capital Institute of Pediatrics, Beijing, China
                [ ]Department of Pediatrics, Peking University First Hospital, Beijing, China
                [ ]Department of Neurology, Affiliated Children’s Hospital of Capital Institute of Pediatrics, Beijing, China
                [ ]Beijing Microread Genetech Co., Ltd, Beijing, China
                [ ]Department of Genetics, Jiangxi Previncial Children’s Hospital, Jiangxi, China
                [ ]State Key Lab of Medical Genetics, Central South University, Changsha, China
                [ ]Research & Technology Development, Asuragen, Inc., Austin, TX USA
                Article
                394
                10.1186/s12887-015-0394-8
                4502947
                26174701
                c0912023-1af8-4184-9af6-0e41cdfa6fe0
                © Chen et al. 2015

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 9 October 2014
                : 25 June 2015
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2015

                Pediatrics
                chinese children,intellectual developmental disorder,fmr1,fragile x syndrome,triplet repeat primed (tp)-pcr

                Comments

                Comment on this article